FDA’s Latest Move Might Not Be All It’s Chalked Up To Be
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is highlighting the benefits of hormone-replacement therapy (HRT) for menopausal women.
“The [Food and Drug Administration (FDA)] is initiating the removal of broad black box warnings from hormone replacement therapy products for menopause,” he said Monday.
For more than two decades, the American medical establishment turned its back on women. Millions of women were told to fear the very therapy that could have given them strength, peace, and dignity through one of life’s most difficult transitions—menopause.
That ends today.
The… pic.twitter.com/PNlFaeCfRJ
— Secretary Kennedy (@SecKennedy) November 10, 2025
Hormone replacement treatments are sold in pill, patch, injection, spray and cream form, to name a few. All come with a black box label — the FDA’s highest safety-related warning.
“Women may be under-utilizing approved therapies that can alleviate menopause symptoms and improve women’s health” because of these warning labels, HHS warned in a press statement released Monday.
Menopause refers to a stage in female life history when she no longer gets periods and can no longer get pregnant. The average age of menopause in the United States is 52, according to the National Institute on Aging (NIA). (Read more from “FDA’s Latest Move Might Not Be All It’s Chalked Up To Be” HERE)
